Literature DB >> 1636841

Seroprevalence of HIV-1 and hepatitis B and C in prostitutes in Albuquerque, New Mexico.

S R Tabet1, D L Palmer, W H Wiese, R E Voorhees, D R Pathak.   

Abstract

A survey of persons soliciting sex in an area known to be frequented by prostitutes in Albuquerque, NM, included 43 females and 66 males. Seroprevalence rates found in this population-based study were as follows: human immunodeficiency virus type 1 (HIV-1), 3%; hepatitis B, 39%; hepatitis C, 45%. Increased age, intravenous drug use, and condom use were independent risk factors for hepatitis B. Female gender and intravenous drug use were independent risk factors for hepatitis C. Neither sharing injection equipment nor engaging in receptive anal intercourse was independently associated with hepatitis B or C.

Entities:  

Mesh:

Year:  1992        PMID: 1636841      PMCID: PMC1695759          DOI: 10.2105/ajph.82.8.1151

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  8 in total

1.  HIV seroprevalence among male IVDUs in Houston, Texas.

Authors:  M L Williams
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

2.  Hepatitis C virus in intravenous drug users.

Authors:  J Bell; R G Batey; G C Farrell; E B Crewe; A L Cunningham; K Byth
Journal:  Med J Aust       Date:  1990-09-03       Impact factor: 7.738

3.  Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.

Authors:  J A van den Hoek; H J van Haastrecht; J Goudsmit; F de Wolf; R A Coutinho
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

4.  Demographic characteristics, risk behaviors, and HIV seroprevalence among intravenous drug users by site of contact: results from a community-wide HIV surveillance project.

Authors:  J McCusker; B Koblin; B F Lewis; J Sullivan
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

5.  Hepatitis B infection in a non-drug abusing prostitute population in Mexico.

Authors:  K C Hyams; J Escamilla; R Lozada Romero; E Macareno Alvarado; N Bonilla Giraldo; T J Papadimos; C Rubio Martinez; P Garcia Gonzalez
Journal:  Scand J Infect Dis       Date:  1990

6.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

7.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

8.  Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States.

Authors:  R F Khabbaz; W W Darrow; T M Hartley; J Witte; J B Cohen; J French; P S Gill; J Potterat; R K Sikes; R Reich
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

  8 in total
  5 in total

1.  HIV and AIDS risk behaviors among female jail detainees: implications for public health policy.

Authors:  Gary Michael McClelland; Linda A Teplin; Karen M Abram; Naomi Jacobs
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

Review 2.  Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.

Authors:  M A Lansang
Journal:  Gut       Date:  1996       Impact factor: 23.059

3.  The consistency of self-reported HIV risk behavior among injection drug users.

Authors:  K McElrath; D D Chitwood; D K Griffin; M Comerford
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

4.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

5.  Infectivity and risk factors of hepatitis C virus transmission through sexual contact.

Authors:  X P Zhao; D L Yang; Z Y Tang; Y C Huang; L J Hao; L Cheng; W Zhou
Journal:  J Tongji Med Univ       Date:  1995
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.